Pharmafile Logo
Pharmafocus logo
Advanced Search
fda2outsideweb

Italian firm warned by FDA over record-shredding and drug quality misrepresentation

February 1, 2017
Manufacturing and Production, Research and Development FACTA Farmaceutici, FDA

Italian drug manufacturer FACTA Farmaceutici has been issued a warning letter by the FDA after being found shredding “critical laboratory …

News
immunisation

African Heads of State commit to universal access to immunisation

February 1, 2017
Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation

The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …

News
donald_trump_september_3_2015

Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices

January 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump

President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …

News
mylan_plus_hero_720x510_1

Antitrust investigation into Mylan begins over EpiPen

January 31, 2017
Research and Development, Sales and Marketing Mylan, pricing

The Federal Trade Commission has submitted a request to Mylan for information as part of a preliminary investigation into whether …

News
anopheles_albimanus_mosquito_web

First-line malaria treatment fails for the first time in UK

January 31, 2017
Manufacturing and Production, Research and Development UK, malaria

The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …

News
insulin-syringe-1972843_960_720

Price-fixing class action lawsuit levelled at three major insulin producers

January 31, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing

A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …

News

Trump’s “one in, two out” regulatory order threatens FDA, Obama Cures Act

January 31, 2017
Manufacturing and Production, Sales and Marketing FDA, Trump

An executive order signed by President Donald Trump on Monday has caused concern in the US pharma industry and beyond …

News
teva_copy

Teva hit by patent blow upon top-selling MS drug

January 31, 2017
Manufacturing and Production Mylan, Teva, generic, multiple sclerosis

Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …

News
money-767778_960_720

1,100% generic cancer drug price increases fly below UK radar

January 30, 2017
Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress

If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …

News
kathleen_tregoning

Sanofi announces new VP of External Affairs

January 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …

Appointment
u_of_liverpool

Major pharma firms join Liverpool Uni in £14m pharmacovigilance project

January 30, 2017
Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance

The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …

News
astellas_japan_headquarters

Astellas and Ironwood release positive Phase 3 results for constipation drug

January 30, 2017
Research and Development, Sales and Marketing Astellas, Ironwood, constipation

Astellas Pharma, a Tokyo-based pharmaceutical, and Ironwood Pharmaceuticals, based in Cambridge, Massachusetts, have announced positive results from a Phase 3 …

News
msd

MSD puts best foot forward in drug pricing debate

January 30, 2017
Medical Communications, Sales and Marketing Drug pricing, MSD, Merck

MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …

News
ema_building_2

Amgen drug pair become first Humira biosimilars to win EU approval

January 30, 2017
Sales and Marketing AbbVie, Amgen, Amgevita, Humira, Solymbic, rheumatoid arthritis

Good news for Amgen as its two biosimilar versions of AbbVie’s blockbuster rheumatoid arthritis (RA) drug Humira (adalimumab) have been …

News
novo_flag

Novo Nordisk launches £115 million investment in UK despite Brexit

January 30, 2017
Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit

Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …

News

Juno Therapeutics bring in new executive vice president

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, juno therapeutics

Juno Therapeutics has hired Corsee D. Sanders as its executive vice president and head of development operations. She will step …

Appointment
revlimid_celgene

Celgene’s Revlimid scores first-of-its-kind myeloma indication in EU

January 27, 2017
Sales and Marketing Celgene, Revlimid, multiple myeloma

Celgene’s Revlimid (lenalidomide) has become the first licensed monotherapy treatment for newly diagnosed multiple myeloma in patients who have undergone …

News
verily_company_logo

Google’s life sciences business gains $800 million funding in pivot to Asia

January 27, 2017
Medical Communications, Sales and Marketing China, Temasek, Verily, google

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

News
money-256281_960_720

Five most talked about mergers and acquisitions of 2016

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

Feature
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

We’re nearing the end of the first month of the year and acqusitions have begun to introduce themselves with bang, …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026